Results 261 to 270 of about 1,417,591 (372)

Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial [PDF]

, 2018
Aimee Campbell, Celestina Barbosa‐Leiker, Mary A. Hatch‐Maillette, Sarah E. Mennenga, Martina Pavlicová, Jennifer Scodes, Tanya C. Saraiya, Shannon Gwin Mitchell, John Rotrosen, Patricia Novo, Edward V. Nunes, Shelly F. Greenfield   +11 more
openalex   +1 more source

Effectiveness of a multimodal physiotherapy program in fighter pilots with flight‐related neck pain: A randomized controlled trial

PM&R, EarlyView.
Abstract Background Flight‐related neck pain constitutes a clinical entity related to the performance, occupational health, and flight safety of fighter pilots. Objective To investigate whether a multimodal physiotherapy program combining supervised motor control exercises with laser‐guided feedback and interferential current therapy with ...
Carlos Fernández‐Morales, Manuel Albornoz‐Cabello, María de los Ángeles Cardero‐Durán, Juan Manuel Moreno‐Vázquez, Luis Espejo‐Antúnez   +4 more
wiley   +1 more source

Medications for opioid use disorder in traditional medicare beneficiaries: associations with age. [PDF]

Health Aff Sch
Ganz DA, Lai J, Cantor JH, Agniel D, Simon K, Stein BD, Taylor EA.   +6 more
europepmc   +1 more source

Changing student attitudes and perceptions toward opioid use disorder [PDF]

, 2018
Haley Countey, Claire Steinbronn, Sarah E. Grady   +2 more
openalex   +1 more source

Pharmacotherapy for Cirrhosis in Japan

Portal Hypertension &Cirrhosis, EarlyView.
As cirrhosis progresses from the compensated to the decompensated stage, liver disease‐related events such as varices, ascites, encephalopathy, sarcopenia, jaundice, and bleeding tendency, as well as liver carcinogenesis, can occur at a high rate. With the advent of new pharmacotherapies for cirrhosis in the last decade, liver fibrosis has been shown ...
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
wiley   +1 more source

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period [PDF]

, 2018
Anna Lembke, Einar Ottestad, Cliff Schmiesing   +2 more
openalex   +1 more source

Intranasal diamorphine population pharmacokinetics modeling and simulation in pediatric breakthrough pain

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 435-447, March 2025.
Abstract Intranasal diamorphine (IND), approved for managing breakthrough pain in the UK, has been identified as an acceptable alternative offering effective, expedient, and less traumatic analgesia for children. However, the current dose regimen in pediatric populations relies on clinical expertise while the pharmacokinetics properties are poorly ...
Lianjin Cai, Jingchen Zhai, Beihong Ji, Fengyang Han, Taoyu Niu, Luxuan Wang, Junmei Wang   +6 more
wiley   +1 more source

Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis. [PDF]

Addict Sci Clin Pract
Lott A, Danner AN, Malte CA, Salameh HA, Bachowski D, Gordon AJ, Hagedorn HJ, Frost MC, Williams EC, Saxon AJ, Trim RS, Hawkins EJ.   +11 more
europepmc   +1 more source

Civil Commitment for Opioid and Other Substance Use Disorders: Does It Work? [PDF]

, 2018
Abhishek Jain, Paul P. Christopher, Paul S. Appelbaum   +2 more
openalex   +1 more source

Formation of a β‐Endorphin Corona Mitigates Alzheimer's Amyloidogenesis

Small, EarlyView.
This study revealed the molecular mechanism of exercise‐induced β‐endorphin in suppressing the toxicity of Alzheimer's Aβ in vitro, in vivo and in silico. Abstract Senile plaques, comprised of nanosized aggregates of amyloid‐β (Aβ) peptides in the brain, are a pathological hallmark of Alzheimer's disease (AD).
Yunxiang Sun, Nicholas Andrikopoulos, Guofang Zhang, Yuying Liu, Xiufang Liang, Dongjie Li, Xiaoman Suo, Yue Wang, Yuhuan Li, Chuang Wang, Yang Li, Pu Chun Ke, Feng Ding   +12 more
wiley   +1 more source